Carba-NAD Binding Activates Sir2 By Reshaping Conformational Plasticity And Rewiring Long-Range Allosteric Networks

Aging Pathway
Therapeutic
Analytical
The binding of a molecule called Carba-NAD activates the SIR2 protein by making its active site more rigid while increasing flexibility in other areas, and by reorganizing its internal communication pathways.
Author

Gemini

Published

March 4, 2026

Have you ever wondered how proteins, the tiny machines in our bodies, can change their behavior in response to other molecules? It’s a bit like a complex dance, where one partner’s move triggers a cascade of reactions in the other. This is called allosteric regulation, and understanding it is key to developing new medicines.

Recent research has shed light on how a specific protein, SIR2, which is known for its role in aging and metabolism, gets activated. Scientists found that when a molecule similar to NAD+ (a vital cellular component) binds to SIR2, it doesn’t just cause a simple, localized change. Instead, it orchestrates a sophisticated transformation within the protein. The area where the work happens, the “active site,” becomes more stable and rigid, allowing it to perform its function more effectively. At the same time, other parts of the protein become more flexible, which might be crucial for its overall operation.

Even more fascinating is how this signal travels through the protein. It’s not a direct line; instead, specific “relay” points, like tiny communication hubs, emerge. These hubs help transmit the activation signal across long distances within the protein, essentially rewiring its internal communication network. This intricate signaling ensures that a local binding event can have a widespread impact on the protein’s function.

Why does this matter? Because SIR2 is involved in processes linked to aging, understanding its activation mechanism opens up exciting possibilities. The research even identified a specific pocket on the protein that could be targeted by new drugs. Imagine developing a molecule that could mimic the activating effect of NAD+, potentially boosting SIR2 activity and offering new avenues for therapies aimed at promoting healthy aging. This discovery provides a concrete target for future drug design, moving us closer to harnessing the power of these molecular dances for better health.


Source: link to paper